{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:33:04Z","timestamp":1767652384030},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1093\/ajcn\/60.5.647","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T21:48:50Z","timestamp":1515188930000},"page":"647-657","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Long-term weight loss: the effect of pharmacologic agents"],"prefix":"10.1016","volume":"60","author":[{"given":"DJ","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JH","family":"Potvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/60.5.647_bib1","first-page":"449","article-title":"Obesity: basic considerations and clinical approaches.","volume":"18","author":"Bray","year":"1989","journal-title":"Dis Mon"},{"key":"10.1093\/ajcn\/60.5.647_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.7326\/0003-4819-103-6-983","article-title":"Health implications of overweight and obesity in the United States.","volume":"103","author":"Van Itallie","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1093\/ajcn\/60.5.647_bib3","article-title":"Anthropometric reference data and prevalence of overweight, United States, 1976-80.","volume":"238","author":"Najjar","year":"1987","journal-title":"Vital Health Stat Ser [11]"},{"key":"10.1093\/ajcn\/60.5.647_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0002-8223(21)01364-X","article-title":"Why treatments for obesity don't last.","volume":"91","author":"Goodrick","year":"1991","journal-title":"J Am Diet Assoc"},{"key":"10.1093\/ajcn\/60.5.647_bib5","doi-asserted-by":"crossref","first-page":"503S","DOI":"10.1093\/ajcn\/55.2.503s","article-title":"Economic cost of obesity.","volume":"55","author":"Colditz","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"suppl 3","key":"10.1093\/ajcn\/60.5.647_bib6","first-page":"13","article-title":"Benefits of reducing\u2014revisited.","volume":"60","author":"Blackburn","year":"1984","journal-title":"Postgrad Med J"},{"key":"10.1093\/ajcn\/60.5.647_bib7","first-page":"1","article-title":"Beneficial health effects of modest weight loss.","volume":"16","author":"Goldstein","year":"1992","journal-title":"Int J Obes"},{"issue":"suppl 2","key":"10.1093\/ajcn\/60.5.647_bib8","first-page":"39","article-title":"Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective.","volume":"13","author":"Wadden","year":"1989","journal-title":"Int J Obes"},{"issue":"suppl 2","key":"10.1093\/ajcn\/60.5.647_bib9","first-page":"91","article-title":"Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine.","volume":"13","author":"Finer","year":"1989","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib10","series-title":"Body-weight evolution during dexfenfluramine treatment after initial weight control.","author":"Finer","year":"1991"},{"key":"10.1093\/ajcn\/60.5.647_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ajcn\/51.4.584","article-title":"Gastric balloon to treat obesity: a double-blind study in nondieting subjects.","volume":"51","author":"Geliebter","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.5.647_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ajcn\/54.2.321","article-title":"Fluoxetine's effect on weight loss in obese subjects.","volume":"54","author":"Darga","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.5.647_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0376-8716(86)90006-2","article-title":"Clinical use of appetite suppressants.","volume":"17","author":"Silverstone","year":"1986","journal-title":"Drug Alcohol Depend"},{"key":"10.1093\/ajcn\/60.5.647_bib14","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","article-title":"International trial of long-term dexfenfluramine in obesity.","volume":"2","author":"Guy-Grand","year":"1989","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/60.5.647_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.1992.68","article-title":"Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 3","key":"10.1093\/ajcn\/60.5.647_bib16","first-page":"19","article-title":"The current status of antiobesity drugs.","volume":"60","author":"Galloway","year":"1984","journal-title":"Postgrad Med J"},{"key":"10.1093\/ajcn\/60.5.647_bib17","series-title":"Obesity in perspective. Proceedings of the Fogarty Conference.","first-page":"441","article-title":"Review of amphetamine-like drugs by the Food and Drug Administration: clinical data and value judgments.","author":"Scoville","year":"1975"},{"key":"10.1093\/ajcn\/60.5.647_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00003495-197611050-00002","article-title":"Anorectic drugs: use in general practice.","volume":"111","author":"Craddock","year":"1976","journal-title":"Drugs"},{"key":"10.1093\/ajcn\/60.5.647_bib19","first-page":"167","article-title":"Pharmacological treatment of obesity.","volume":"2","author":"Sullivan","year":"1978","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00844268","article-title":"Limitations of behavioral treatment of obesity: review and analysis.","volume":"4","author":"Foreyt","year":"1981","journal-title":"J Behav Med"},{"key":"10.1093\/ajcn\/60.5.647_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0163-7258(82)90037-7","article-title":"Drug treatment and obesity.","volume":"18","author":"Douglas","year":"1982","journal-title":"Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30698-8","article-title":"Behavioral management of obesity.","volume":"73","author":"Brownell","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1093\/ajcn\/60.5.647_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0025-7125(16)30701-5","article-title":"Drug treatment of obesity.","volume":"73","author":"Weintraub","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1093\/ajcn\/60.5.647_bib24","first-page":"249","article-title":"Drugs for the treatment of obesity.","volume":"4","author":"Wilson","year":"1990","journal-title":"Pharmaceut Med"},{"key":"10.1093\/ajcn\/60.5.647_bib25","first-page":"1153","article-title":"Clinical review 28.","volume":"73","author":"Hirsch","year":"1991","journal-title":"A biological basis for human obesity. Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/60.5.647_bib26","doi-asserted-by":"crossref","first-page":"211S","DOI":"10.1093\/ajcn\/55.1.211s","article-title":"Centrally acting anorectic drugs: a clinical perspective.","volume":"55","author":"Silverstone","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.5.647_bib27","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.1987.00370100063012","article-title":"Long-term effects of modest weight loss in type II diabetic patients.","volume":"147","author":"Wing","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1093\/ajcn\/60.5.647_bib28","first-page":"123","article-title":"Long-term follow-up of behavioral treatment for obesity: patterns of regain among men and women.","volume":"13","author":"Kramer","year":"1989","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib29","first-page":"195","article-title":"The historical development, efficacy and safety of very-low-calorie diets.","volume":"5","author":"Howard","year":"1981","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1037\/0022-006X.56.6.925","article-title":"Three-year follow-up of the treatment of obesity by very low calorie diet, behavior therapy, and their combination.","volume":"56","author":"Wadden","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"10.1093\/ajcn\/60.5.647_bib31","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.1990.00390170066015","article-title":"The Toledo exercise and diet study: results at 26 weeks.","volume":"150","author":"Leighton","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1093\/ajcn\/60.5.647_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.1.5588.352","article-title":"Comparison of continuous and intermittent anorectic therapy in obesity.","volume":"1","author":"Munro","year":"1968","journal-title":"Br Med J"},{"key":"10.1093\/ajcn\/60.5.647_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1742-1241.1965.tb03144.x","article-title":"The long-term management of obesity in general practice.","volume":"19","author":"Silverstone","year":"1965","journal-title":"Br J Clin Pract"},{"key":"10.1093\/ajcn\/60.5.647_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1185\/03007997309111712","article-title":"Long-term use of diethylpropion in obesity.","volume":"1","author":"McKay","year":"1973","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/ajcn\/60.5.647_bib35","first-page":"1","article-title":"New weight standards for men and women.","volume":"40","year":"1959","journal-title":"Stat Bull Metropol Life Insur Co"},{"key":"10.1093\/ajcn\/60.5.647_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/030006057600400504","article-title":"Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.","volume":"4","author":"Enzi","year":"1976","journal-title":"J Int Med Res"},{"key":"10.1093\/ajcn\/60.5.647_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1992.69","article-title":"Long-term weight control study I (weeks 0 to 34): the enhancement of behavior modification, caloric restriction and exercise by fenfluramine plus phentermine versus placebo.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1992.70","article-title":"Long-term weight control study II (weeks 34 to 104): an open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/clpt.1992.71","article-title":"Long-term weight control study III (weeks 104 to 156): an open-label study of dose adjustment of fenfluramine and phentermine.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/clpt.1992.72","article-title":"Long-term weight control study IV (weeks 156-190): the second double-blind phase.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/clpt.1992.73","article-title":"Long-term weight control study V (weeks 190 to 210): follow-up of participants after cessation of medication.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/clpt.1992.74","article-title":"Long-term weight control study VI: individual participant response patterns.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib43","series-title":"Medico-actuarial mortality investigation.","year":"1912"},{"key":"10.1093\/ajcn\/60.5.647_bib44","first-page":"497","article-title":"The anorectic and hypotensive effect of fenfluramine in obesity.","volume":"27","author":"Hudson","year":"1977","journal-title":"J R Coll Gen Pract"},{"key":"10.1093\/ajcn\/60.5.647_bib45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(80)92272-2","article-title":"Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity.","volume":"2","author":"Stunkard","year":"1980","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/60.5.647_bib46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archpsyc.1981.01780320043003","article-title":"Behavior therapy and pharmacotherapy for obesity.","volume":"38","author":"Craighead","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1093\/ajcn\/60.5.647_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0140-6736(83)91501-5","article-title":"Long-term efficacy of fenfluramine in treatment of obesity.","volume":"1","author":"Douglas","year":"1983","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/60.5.647_bib48","first-page":"247","article-title":"Long-term treatment with fenfluramine in obese subjects.","volume":"4","author":"Sensi","year":"1985","journal-title":"Int J Clin Pharm Res"},{"key":"10.1093\/ajcn\/60.5.647_bib49","first-page":"232","article-title":"A comparative trial of different regimens of fenfluramine and phentermine in obesity.","volume":"211","author":"Steel","year":"1973","journal-title":"Practitioner"},{"key":"10.1093\/ajcn\/60.5.647_bib50","first-page":"2","article-title":"1983 Height and weight tables.","volume":"64","year":"1983","journal-title":"Stat Bull Metropol Life Insur Co."},{"key":"10.1093\/ajcn\/60.5.647_bib51","first-page":"847","article-title":"Dextrofenfluramine in the treatment of refractory obesity.","volume":"38","author":"Finer","year":"1985","journal-title":"Curr Ther Res"},{"key":"10.1093\/ajcn\/60.5.647_bib52","first-page":"598","article-title":"Prolonged weight loss with dexfenfluramine treatment in obese patients.","volume":"13","author":"Finer","year":"1987","journal-title":"Diabete Metab"},{"key":"10.1093\/ajcn\/60.5.647_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0248-8663(89)80015-3","article-title":"International study of the effect of dexfenfluramine in obesity: 6-month results. (\u00c9tude internationale de l\u2019effet de la dexfenfluramine dans l\u2019obesit\u00e9 (ISIS): r\u00e9sultats \u00e0 6 mois.)","volume":"10","author":"Guy-Grand","year":"1989","journal-title":"Rev Med Interne"},{"key":"10.1093\/ajcn\/60.5.647_bib54","first-page":"35","article-title":"Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial.","volume":"16","author":"Andersen","year":"1992","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib55","first-page":"612","article-title":"A six-month study of the effects of dexfenfluramine on partially successful dieters.","volume":"47","author":"Noble","year":"1990","journal-title":"Curr Ther Res"},{"issue":"suppl","key":"10.1093\/ajcn\/60.5.647_bib56","first-page":"A124","article-title":"Improvement of glycemic control and weight loss in type 2 (non-insulin-dependent) diabetics after one year of dexfenfluramine treatment.","volume":"33","author":"Tauber-Lassen","year":"1990","journal-title":"Diabetologia"},{"key":"10.1093\/ajcn\/60.5.647_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2796.1992.tb00560.x","article-title":"Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour.","volume":"232","author":"Mathus-Vliegen","year":"1992","journal-title":"J Intern Med"},{"issue":"suppl 2","key":"10.1093\/ajcn\/60.5.647_bib58","first-page":"154A","article-title":"Fluoxetine has potential in obese NIDDM\u2014multi-center Canadian trial.","volume":"38","author":"Chiasson","year":"1989","journal-title":"Diabetes"},{"key":"10.1093\/ajcn\/60.5.647_bib59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.147.7.876","article-title":"A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters.","volume":"147","author":"Marcus","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1093\/ajcn\/60.5.647_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/j.1550-8528.1993.tb00597.x","article-title":"Fluoxetine: a randomized clinical trial in the maintenance of weight loss.","volume":"1","author":"Goldstein","year":"1993","journal-title":"Obes Res"},{"key":"10.1093\/ajcn\/60.5.647_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2337\/diacare.12.2.139","article-title":"Behavioral strategy for weight reduction in obese type II diabetic patients.","volume":"12","author":"Wing","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1093\/ajcn\/60.5.647_bib62","first-page":"113","article-title":"Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial.","volume":"1","author":"Atkinson","year":"1977","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib63","first-page":"171","article-title":"Clinical aspects of the treatment of obesity by drugs: a review.","volume":"3","author":"Munro","year":"1979","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib64","first-page":"528","article-title":"The regulation of body weight.","volume":"79","author":"Martin","year":"1991","journal-title":"Am Sci"},{"key":"10.1093\/ajcn\/60.5.647_bib65","first-page":"79","article-title":"Predictors of successful weight loss in an outpatient obesity clinic.","volume":"1","author":"Rodin","year":"1977","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1542\/peds.84.2.374","article-title":"Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians.","volume":"84","author":"Hetherington","year":"1989","journal-title":"Pediatrics"},{"key":"10.1093\/ajcn\/60.5.647_bib67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0140-6736(91)90201-Y","article-title":"Publication bias in clinical research.","volume":"337","author":"Easterbrook","year":"1991","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/60.5.647_bib68","first-page":"281","article-title":"Pattern analysis method for assessing successful weight reduction.","volume":"18","author":"Holman","year":"1994","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.5.647_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0021-9681(74)90079-4","article-title":"Relation of weight change to changes in atherogenic traits: the Framingham study.","volume":"27","author":"Ashley","year":"1974","journal-title":"J Chronic Dis"},{"key":"10.1093\/ajcn\/60.5.647_bib70","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/clpt.1992.75","article-title":"Long-term weight control study VII (weeks 0 to 210): serum lipid changes.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.5.647_bib71","doi-asserted-by":"crossref","first-page":"55G","DOI":"10.1016\/0002-9149(87)90592-3","article-title":"Medical evaluation of the obese patient with cardiovascular disease.","volume":"60","author":"Blackburn","year":"1987","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523185005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523185005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/60\/5\/647\/24114769\/647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:15:11Z","timestamp":1686287711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523185005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["S0002916523185005"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/60.5.647","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[1994,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term weight loss: the effect of pharmacologic agents","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/60.5.647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1994 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}